Michael H Carrel Atri Cure, Inc. (ATRC) insider trading activity

ATRC Quotes by TradingView

Michael H Carrel is President, CEO, & Director of AtriCure, Inc.. Currently has a direct ownership of 706,555 shares of ATRC, which is worth approximately $22.5 Million. The most recent transaction as insider was on Dec 18, 2020, when has been sold 50,249 shares (Common Stock) at a price of $53.51 per share, resulting in proceeds of $2,688,824. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 707K
8.16% 3M change
7.78% 12M change
Total Value Held $22.5 Million

MICHAEL H CARREL Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 18 2020
SELL
Open market or private sale
$2,688,824 $53.51 p/Share
50,249 Reduced 9.06%
504,504 Common Stock
Dec 18 2020
BUY
Exercise of conversion of derivative security
$1,057,239 $21.04 p/Share
50,249 Added 8.31%
554,753 Common Stock
Dec 17 2020
SELL
Open market or private sale
$3,825,000 $51.0 p/Share
75,000 Reduced 12.94%
504,504 Common Stock
Dec 17 2020
BUY
Exercise of conversion of derivative security
$821,250 $10.95 p/Share
75,000 Added 12.41%
529,504 Common Stock

Also insider at

AXNX
Axonics, Inc. Healthcare
MHC

Michael H Carrel

President, CEO, & Director
Mason, OH

Track Institutional and Insider Activities on ATRC

Follow AtriCure, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATRC shares.

Notify only if

Insider Trading

Get notified when an Atri Cure, Inc. insider buys or sells ATRC shares.

Notify only if

News

Receive news related to AtriCure, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATRC